AllianceBernstein
NXTC icon

AllianceBernstein’s NextCure NXTC Stock Holding History

AllianceBernstein’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-937
Closed -$123K – 3281
2020
Q4 		$123K Sell
937
-176
-16% -$22.7K ﹤0.01% 3084
2020
Q3 		$118K Sell
1,113
-114,868
-99% -$14.1M ﹤0.01% 3054
2020
Q2 		$29.8M Buy
115,981
+11,477
+11% +$4.37M 0.02% 650
2020
Q1 		$46.5M Buy
104,504
+15,897
+18% +$8.49M 0.03% 467
2019
Q4 		$59.9M Buy
88,607
+41,206
+87% +$20.7M 0.03% 501
2019
Q3 		$17.5M Sell
47,401
-10,708
-18% -$3.48M 0.01% 835
2019
Q2 		$10.4M Buy
+58,109
New +$12.1M 0.01% 1036

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

AllianceBernstein's NXTC Position: Q1 2021 in Review

AllianceBernstein sold out of NextCure (NXTC) in Q1 2021, closing a stake of 937 shares — an estimated $123K sold.

AllianceBernstein first reported a position in NXTC in Q2 2019 and held it in 7 quarters. The position peaked at $59.9M in Q4 2019. 92 funds tracked by Wall St. Rank hold NXTC as of Q1 2021.

  • AllianceBernstein reported no remaining NextCure position as of Q1 2021 after selling out during the quarter.
  • AllianceBernstein sold 937 NextCure shares in Q1 2021, an estimated $123K.
  • AllianceBernstein first reported a position in NextCure in Q2 2019 and held it in 7 quarters.
  • AllianceBernstein's NextCure position peaked at $59.9M in Q4 2019.
  • 92 funds tracked by Wall St. Rank held NextCure as of Q1 2021.

Based on AllianceBernstein's 13F filing for Q1 2021, filed 6 May 2021.